| Authors: |
Lewis DY; Cancer Research United Kingdom-Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom., Boren J; Cancer Research United Kingdom-Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom., Shaw GL; Cancer Research United Kingdom-Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom., Bielik R; Cancer Research United Kingdom-Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom., Ramos-Montoya A; Cancer Research United Kingdom-Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom., Larkin TJ; Cancer Research United Kingdom-Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom; and., Martins CP; MRC Cancer Unit, University of Cambridge, Cambridge, United Kingdom., Neal DE; Cancer Research United Kingdom-Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom., Soloviev D; Cancer Research United Kingdom-Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom., Brindle KM; Cancer Research United Kingdom-Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom; and kmb1001@cam.ac.uk. |